Maculaser
Helsinki, FI · Founded 2020 · 5 employees on LinkedIn · 2 known investors
Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.
Founders & leadership
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundSep 2021
Innovestor Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Maculaser do?
- Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.
- Who are Maculaser's investors?
- Maculaser's investors include Innovestor Ventures, ZEISS Ventures.
- Where is Maculaser headquartered?
- Maculaser is headquartered in Helsinki, FI.





